GAD65 as a prototypic autoantigen

Journal of Autoimmunity

Volumn 31, Issue 3, 2008, Pages 228-232

  Fenalti, Gustavo ^a   Rowley, Merrill J ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Antigenicity; Autoepitopes; Epitope structure; Glutamic acid decarboxylase; Type 1 diabetes

Indexed keywords

AUTOANTIGEN; EPITOPE; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67;

ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CRYSTAL STRUCTURE; ENZYME STRUCTURE; INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; AUTOANTIGENS; B-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; EPITOPE MAPPING; EPITOPES; GLUTAMATE DECARBOXYLASE; HUMANS; MICE; PROTEIN CONFORMATION; PROTEIN ISOFORMS; T-LYMPHOCYTE SUBSETS;

EID: 56349160583     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2008.04.013     Document Type: Article

References (46)

1. Mackay I.R., and Burnet F.M. Autoimmune diseases pathogenesis, chemistry and therapy (1963), Thomas, Springfield, IL
2. Plotz P.H. The autoantibody repertoire: searching for order. Nat Rev Immunol 3 (2003) 73-78
3. Lernmark A. Glutamic acid decarboxylase - gene to antigen to disease. J Intern Med 240 (1996) 259-277
4. Tuomi T., Groop L.C., Zimmet P.Z., Rowley M.J., Knowles W., and Mackay I.R. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 42 (1993) 359-362
5. Groop L., Tuomi T., Rowley M., Zimmet P., and Mackay I.R. Latent autoimmune diabetes in adults (LADA) - more than a name. Diabetologia 49 (2006) 1996-1998
6. Baekkeskov S., Aanstoot H.J., Christgau S., Reetz A., Solimena M., Cascalho M., et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347 (1990) 151-156
7. Tuomilehto J., Zimmet P., Mackay I.R., Koskela P., Vidgren G., Toivanen L., et al. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. Lancet 343 (1994) 1383-1385
8. Lernmark A., and Agardh C.D. Immunomodulation with human recombinant autoantigens. Trends Immunol 26 (2005) 608-612
9. Fenalti G., Law R.H., Buckle A.M., Langendorf C., Tuck K., Rosado C.J., et al. GABA production by glutamic acid decarboxylase is regulated by a dynamic catalytic loop. Nat Struct Mol Biol 14 (2007) 280-286
10. Schwartz H.L., Chandonia J.M., Kash S.F., Kanaani J., Tunnell E., Domingo A., et al. High-resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylase. J Mol Biol 287 (1999) 983-999
11. O'Connor K.H., Banga J.P., Darmanin C., El-Kabbani O., Mackay I.R., and Rowley M.J. Characterisation of an autoreactive conformational epitope on GAD65 recognised by the human monoclonal antibody b78 using a combination of phage display, in vitro mutagenesis and molecular modelling. J Autoimmun 26 (2006) 172-181
12. Fenalti G., Hampe C.S., Law R.H., Arafat Y., Banga J.P., Mackay I.R., et al. COOH terminal clustering of autoantibody and T cell determinants on the structure of GAD65 provide insights into the molecular basis of autoreactivity. Diabetes 57 (2008) 1293-1301
13. Bingley P.J., Bonifacio E., Williams A.J., Genovese S., Bottazzo G.F., and Gale E.A. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 46 (1997) 1701-1710
14. Richter W., Endl J., Eiermann T.H., Brandt M., Kientsch-Engel R., Thivolet C., et al. Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen. Proc Natl Acad Sci U S A 89 (1992) 8467-8471
15. Madec A.M., Rousset F., Ho S., Robert F., Thivolet C., Orgiazzi J., et al. Four IgG anti-islet human monoclonal antibodies isolated from a type 1 diabetes patient recognize distinct epitopes of glutamic acid decarboxylase 65 and are somatically mutated. J Immunol 156 (1996) 3541-3549
16. Syren K., Lindsay L., Stoehrer B., Jury K., Luhder F., Baekkeskov S., et al. Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase. J Immunol 157 (1996) 5208-5214
17. Tremble J., Morgenthaler N.G., Vlug A., Powers A.C., Christie M.R., Scherbaum W.A., et al. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes. J Clin Endocrinol Metab 82 (1997) 2664-2670
18. Richter W., Seissler J., Northemann W., Wolfahrt S., Meinck H.M., and Scherbaum W.A. Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome. Diabetes 42 (1993) 1642-1648
19. Padoa C.J., Banga J.P., Madec A.M., Ziegler M., Schlosser M., Ortqvist E., et al. Recombinant Fabs of human monoclonal antibodies specific to the middle epitope of GAD65 inhibit type 1 diabetes-specific GAD65Abs. Diabetes 52 (2003) 2689-2695
20. Raju R., Foote J., Banga J.P., Hall T.R., Padoa C.J., Dalakas M.C., et al. Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients. J Immunol 175 (2005) 7755-7762
21. Bingley P.J., Bonifacio E., and Mueller P.W. Diabetes Antibody Standardization Program: first assay proficiency evaluation. Diabetes 52 (2003) 1128-1136
22. Fenalti G., Hampe C.S., O'Connor K., Banga J.P., Mackay I.R., Rowley M.J., et al. Molecular characterization of a disease associated conformational epitope on GAD65 recognised by a human monoclonal antibody b96.11. Mol Immunol 44 (2007) 1178-1189
23. Kim J., Namchuk M., Bugawan T., Fu Q., Jaffe M., Shi Y., et al. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J Exp Med 180 (1994) 595-606
24. Di Lorenzo T.P., Peakman M., and Roep B.O. Translational mini-review series on type 1 diabetes: systematic analysis of T cell epitopes in autoimmune diabetes. Clin Exp Immunol 148 (2007) 1-16
25. Hampe C.S., Kockum I., Landin-Olsson M., Torn C., Ortqvist E., Persson B., et al. GAD65 antibody epitope patterns of type 1.5 diabetic patients are consistent with slow-onset autoimmune diabetes. Diabetes Care 25 (2002) 1481-1482
26. Kobayashi T., Tanaka S., Okubo M., Nakanishi K., Murase T., and Lernmark A. Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes. J Clin Endocrinol Metab 88 (2003) 4768-4775
27. Hampe C.S., Hall T.R., Agren A., and Rolandsson O. Longitudinal changes in epitope recognition of autoantibodies against glutamate decarboxylase 65 (GAD65Ab) in prediabetic adults developing diabetes. Clin Exp Immunol 148 (2007) 72-78
28. Hampe C.S., Nalini R., Maldonado M.R., Hall T.R., Garza G., Iyer D., et al. Association of amino-terminal-specific antiglutamate decarboxylase (GAD65) autoantibodies with beta-cell functional reserve and a milder clinical phenotype in patients with GAD65 antibodies and ketosis-prone diabetes mellitus. J Clin Endocrinol Metab 92 (2007) 462-467
29. Schlosser M., Banga J.P., Madec A.M., Binder K.A., Strebelow M., Rjasanowski I., et al. Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes. Diabetologia 48 (2005) 922-930
30. Dai Y.D., Jensen K.P., Lehuen A., Masteller E.L., Bluestone J.A., Wilson D.B., et al. A peptide of glutamic acid decarboxylase 65 can recruit and expand a diabetogenic T cell clone, BDC2.5, in the pancreas. J Immunol 175 (2005) 3621-3627
31. Dai Y.D., Carayanniotis G., and Sercarz E. Antigen processing by autoreactive B cells promotes determinant spreading. Cell Mol Immunol 2 (2005) 169-175
32. Chao C.C., and McDevitt H.O. Identification of immunogenic epitopes of GAD 65 presented by Ag7 in non-obese diabetic mice. Immunogenetics 46 (1997) 29-34
33. Nepom G.T., Lippolis J.D., White F.M., Masewicz S., Marto J.A., Herman A., et al. Identification and modulation of a naturally processed T cell epitope from the diabetes-associated autoantigen human glutamic acid decarboxylase 65 (hGAD65). Proc Natl Acad Sci U S A 98 (2001) 1763-1768
34. Patel S.D., Cope A.P., Congia M., Chen T.T., Kim E., Fugger L., et al. Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 by using HLA-DR(alpha1*0101,beta1*0401) transgenic mice. Proc Natl Acad Sci U S A 94 (1997) 8082-8087
35. Wicker L.S., Chen S.L., Nepom G.T., Elliott J.F., Freed D.C., Bansal A., et al. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. J Clin Invest 98 (1996) 2597-2603
36. Panina-Bordignon P., Lang R., van Endert P.M., Benazzi E., Felix A.M., Pastore R.M., et al. Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J Exp Med 181 (1995) 1923-1927
37. Mackay I.R., and Rowley M.J. Autoimmune epitopes: autoepitopes. Autoimmun Rev 3 (2004) 487-492
38. Banga J.P., Moore J.K., Duhindan N., Madec A.M., van Endert P.M., Orgiazzi J., et al. Modulation of antigen presentation by autoreactive B cell clones specific for GAD65 from a type I diabetic patient. Clin Exp Immunol 135 (2004) 74-84
39. Jaume J.C., Parry S.L., Madec A.M., Sonderstrup G., and Baekkeskov S. Suppressive effect of glutamic acid decarboxylase 65-specific autoimmune B lymphocytes on processing of T cell determinants located within the antibody epitope. J Immunol 169 (2002) 665-672
40. Harbers S.O., Crocker A., Catalano G., D'Agati V., Jung S., Desai D.D., et al. Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance. J Clin Invest 117 (2007) 1361-1369
41. Quaratino S., Ruf J., Osman M., Guo J., McLachlan S., Rapoport B., et al. Human autoantibodies modulate the T cell epitope repertoire but fail to unmask a pathogenic cryptic epitope. J Immunol 174 (2005) 557-563
42. Wong F.S., Wen L., Tang M., Ramanathan M., Visintin I., Daugherty J., et al. Investigation of the role of B-cells in type 1 diabetes in the NOD mouse. Diabetes 53 (2004) 2581-2587
43. Carmicle S., Steede N.K., and Landry S.J. Antigen three-dimensional structure guides the processing and presentation of helper T-cell epitopes. Mol Immunol 44 (2007) 1159-1168
44. Surman S., Lockey T.D., Slobod K.S., Jones B., Riberdy J.M., White S.W., et al. Localization of CD4+ T cell epitope hotspots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing. Proc Natl Acad Sci U S A 98 (2001) 4587-4592
45. Paus D., and Winter G. Mapping epitopes and antigenicity by site-directed masking. Proc Natl Acad Sci U S A 103 (2006) 9172-9177
46. James L.C., and Tawfik D.S. The specificity of cross-reactivity: promiscuous antibody binding involves specific hydrogen bonds rather than nonspecific hydrophobic stickiness. Protein Sci 12 (2003) 2183-2193